insights_auto
Why is 4142 down 6,62%?
Dive Deeperchevron_right
4142:TPE
Adimmune Corp
14,80 TWD
arrow_downward
-6,62%(-1,05) 1D
20-ноя., 13:30:09 GMT+8 · TWD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for 4142...
Open
15,75 TWD
High
15,75 TWD
Low
14,80 TWD
Mkt. cap
6,36 млд
Avg. vol.
1,13 млн
Volume
1,63 млн
P/E ratio
85,76
52-wk high
21,50 TWD
52-wk low
14,80 TWD
EPS
0,17 TWD
Shares outstanding
235,29 млн
No. of employees
564
Open
15,75 TWD
High
15,75 TWD
Low
14,80 TWD
Mkt. cap
6,36 млд
Avg. vol.
1,13 млн
Volume
1,63 млн
P/E ratio
85,76
52-wk high
21,50 TWD
52-wk low
14,80 TWD
EPS
0,17 TWD
Shares outstanding
235,29 млн
No. of employees
564
News stories
From web sources and news partners
ChartMill
·
1 саат мурун
S&P 500 Most Active Stocks: Netflix and Ford Lead Volume
marketscreener.com
·
57 мүнөт мурун
S&P 500, Dow Enter Correction Territory; Anthropic Tumbles Following Record Debut
GV Wire
·
33 мүнөт мурун
Wall Street Slides on Mounting AI Selloff, S&P 500, Dow Set to Confirm Corrections
Profile
Adimmune Corporation is a Taiwanese pharmaceutical company engaged in the research, development, manufacturing, and sales of medicines and vaccines for both humans and animals. Its products are supplied to both local and international markets.
Founded in 1965 and headquartered in Tanzi District, Taichung, it has a market cap of US$230 million, 564 employees and annual sales of $106 million as of 2026.
Adimmune continues to seek expansion its role in the regional pharmaceutical and vaccine industry through international collaborations.
In January 2021, Adimmune Corporation announced a partnership with Sam Chun Dang Pharm to jointly develop an injectable medication used to treat macular disease.
In July 2021, the company announced that its first overseas manufacturing site will be situated in the Special Economic Zone in East Java, Indonesia, aiming to launch clinical trials for its COVID-19 vaccine in Indonesia early 2022.
In August 2021, Adimmune Corporation signed a memorandum of understanding with Becton, Dickinson and Company to strengthen its international pharmaceutical collaboration. Wikipedia
About Adimmune Corp